1. Home
  2. LMNR vs PROK Comparison

LMNR vs PROK Comparison

Compare LMNR & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$12.68

Market Cap

233.9M

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.89

Market Cap

296.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
PROK
Founded
1893
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.9M
296.8M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
LMNR
PROK
Price
$12.68
$1.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$20.00
$7.40
AVG Volume (30 Days)
53.4K
935.2K
Earning Date
06-08-2026
05-08-2026
Dividend Yield
2.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$159,723,000.00
$893,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$13.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1075.00
52 Week Low
$12.20
$0.54
52 Week High
$17.11
$7.13

Technical Indicators

Market Signals
Indicator
LMNR
PROK
Relative Strength Index (RSI) 44.16 46.45
Support Level $12.54 $1.71
Resistance Level $13.60 $2.58
Average True Range (ATR) 0.39 0.12
MACD 0.01 -0.01
Stochastic Oscillator 38.05 32.95

Price Performance

Historical Comparison
LMNR
PROK

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: